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Due to its unique characteristics, the cornea has been widely used for vascular research. However, it has never been studied
whether lymphatic vessels in the conjunctiva, its neighboring tissue, are aﬀected by corneal lymphangiogenesis (LG). The purpose
of this study was to investigate whether the distribution pattern of conjunctival lymphatic vessels changes during LG using a
standardized two-suture placement model. Our data from immunoﬂuorescent microscopic studies demonstrate, for the ﬁrst
time, that conjunctival lymphatic vessels were more distributed in the nasal side under both normal and inﬂamed conditions.
Additionally, under the inﬂamed condition, conjunctival lymphatic vessels showed a higher density and more branching points,
indicating that LG occurs in the conjunctiva in response to corneal inﬂammation. This study not only provides novel insights
into lymphatic events in the ocular surface but also oﬀers new guidelines for developing therapeutic strategies to treat lymphatic
diseases at related sites.
1.Introduction
Lymphangiogenesis (LG) has emerged as a new ﬁeld to un-
derstand the fundamental mechanisms of a wide spectrum
of physiological and pathological conditions. Lymphatic
network penetrates most tissues in the body and plays
critical role in many functions, which include immune
responses, fat and vitamin absorption, and body ﬂuid
regulation. Numerous diseases and conditions are therefore
associated with lymphatic dysfunction, such as inﬂam-
matory diseases, transplant rejection, cancer metastasis,
autoimmune diseases, and lymphedema [1–6]. Unlike blood
vessels, lymphatics are not easily visible. However, the recent
identiﬁcation of several lymphatic-speciﬁc markers, such as
lymphatic vessel endothelial hyaluronan receptor-1 (LYVE-
1), vascular endothelial growth factor receptor-3 (VEGFR-
3), and Prospero homeobox protein 1 (Prox1) has allowed
scientists to further study LG mechanisms [2, 7–9]. The
cornea has been a model of choice for LG investigation
due to its unique characteristics [10–12]. As the forefront
medium in the passage of light to the retina, it is transparent
by nature and devoid of any vasculatures. Nevertheless, its
neighboring tissue, the conjunctiva, has a rich supply of both
blood and lymphatic vessels [12]. As a major component of
the immune reﬂex arc [4], the lymphatic channel facilitates
thetraﬃckingofantigen-presentingcellsfromtheperipheral
tissue (e.g., ocular surface) to draining lymph nodes. It
therefore provides a therapeutic target in immunogenic
disorders such as corneal transplant rejection [13–16].
Whilemostofthepreviousstudiesonlymphaticresearch
in the ocular surface have focused on the cornea, to date, it
still remains largely unknown how conjunctival lymphatic
vessels are distributed and whether they respond to patho-
logical stimulations at the cornea. Using a standardized two-
suture placement model for corneal inﬂammation [17], we
herein provide the ﬁrst evidence showing a nasal dominant
distribution of lymphatic vessels in the conjunctiva under
both normal and inﬂamed conditions. Moreover, we report
a novel ﬁnding that corneal inﬂammation not only induces
LG at the site, but also in the neighboring tissue of the
conjunctiva. These results oﬀer new insights into ocular
surface anatomy and pathogenesis, which are also important2 Journal of Ophthalmology
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Figure 1: Schematic picture illustrating the suture placement method used to compare the nasal and temporal distributions of vessels. Two
sutures were placed at 3 and 9 o’clock of the cornea, respectively. Outer grey area: conjunctiva; Middle white circle: cornea; Inner circle:
demarcation of the central cornea with the trephine where sutures were placed. Dashed line: demarcation between the nasal and temporal
side.
for developing more eﬀective therapeutic strategies to treat
relevant diseases.
2. Methods
2.1. Animal. 6 to 8-week-old male BALB/c (Taconic Farms,
Germantown, NY) were used for the experiments. All mice
were treated according to ARVO Statement for the Use
of Animals in Ophthalmic and Vision Research, and all
protocols were approved by the Animal Care and Use
Committee, University of California, Berkeley. Mice were
anesthetized using a mixture of ketamine, xylazine, and
acepromazine (50mg, 10mg, and 1mg/kg body weight,
resp.) for each surgical procedure.
2.2. Corneal Suture Placement. Our standard two-suture
placement model was used to induce corneal inﬂammation
as described previously [17]. Brieﬂy, to appreciate the nasal
versus temporal distributions of the vessels, two diametri-
cally opposed 11–0 nylon sutures (AROSurgical, Newport
Beach, CA) were placed at 3pm and 9pm of the cornea
following a demarcation of a 1.5mm trephine (Figure 1).
Two weeks later, perilimbal bulbar conjunctivae (deﬁned as
a ring area 0.8mm distal to the limbal vasculatures) were
collected for immunoﬂuorescent microscopic studies. The
experiments were repeated twice with 7 mice in the normal
and sutured group, respectively.
2.3. Immunoﬂuorescent Microscopic Studies. The experi-
ments were performed according to our standard protocol
[17–20]. Brieﬂy, freshly excised tissues, labeled at 6pm for
orientation, were ﬁxed in acetone for immunoﬂuorescent
staining. Nonspeciﬁc staining was blocked with 10% donkey
serum and 2% BSA. The samples were stained overnight
with puriﬁed rabbit anti-mouse LYVE-1 antibody (1:200
dilution; Abcam, Cambridge, MA). After thorough washings
in PBS, samples were incubate with a rhodamine conjugated
donkey anti-rabbit secondary antibody (1:200 dilution;
Jackson ImmunoResearch, West Grove, PA) for 2 hours
at room temperature. Samples were covered with Vector
Shield mounting medium (Vector Laboratories, Burlingame,
CA) and examined by an epiﬂuorescence deconvolution
microscope (AxioImager M1, Carl Zeiss AG, Gottingen,
Germany).
2.4. Vascular Quantiﬁcation. Lymphatic density in the per-
ilimbal bulbar conjunctival area was graded and analyzed
usingtheNIHImageJsoftware,asdescribedpreviously[21].
Basically individual lymphatic vessels in the deﬁned area
were highlighted and added together to generate a density
score measured in pixels for each sample analyzed. The nasal
and temporal sides were divided by a midline across 6 and 12
o’clock (Figure 1).
2.5. Statistical Analysis. Data are expressed as the mean ±
SEM. The statistical signiﬁcance of the diﬀerence between
each group was evaluated using student t test with GraphPad
Prism software (GraphPad Software, Inc., La Jolla, CA). P<
0.05 was considered signiﬁcant.
3. Results
3.1. Conjunctival Lymphatic Vessels Observe a Nasal Domi-
nant Distribution under Normal Condition. We ﬁrst set toJournal of Ophthalmology 3
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Figure 2: Comparison of lymphatic distribution in the nasal versus temporal side of normal conjunctiva. (a) Representative
immunoﬂuorescent micrographs demonstrating that lymphatic vessels were more prominent in the nasal side. LYVE-1: red; Original
Magniﬁcation: ×50. (b) Summary of repetitive experiments.∗P<0.05.
investigate normal distribution of lymphatic vessels in the
conjunctiva using a speciﬁc antibody against the lymphatic
marker LYVE-1. Our results from the immunoﬂuorescent
microscopic studies conﬁrmed that in the normal setting,
the conjunctiva was endowed with lymphatic vessels. Sur-
prisingly, it was also found that these vessels were not
evenlydistributedaroundtheclock.AsshowninFigure 2(a),
conjunctival lymphatic vessels were present more frequently
in the nasal side. The results from repetitive studies were
summarized in Figure 2(b) (P<0.05).
3.2. Conjunctival Lymphatic Density is Increased during
Corneal Inﬂammation. We next examined whether con-
junctival lymphatic vasculatures were aﬀected by corneal
inﬂammation using the two-suture placement model as
previously described [17] and further illustrated in Figure 1.
This particular model with two equally placed sutures
allowed us to perform a precise evaluation between the
nasal and temporal sides of the ocular surface. As shown
in Figure 3(a), a signiﬁcant increase of lymphatic vessels
was observed in the conjunctiva after the inﬂammatory
stimulation in the cornea. Summarized data from repetitive
experiments were presented in Figure 3(b) (P<0.05).
3.3. Conjunctival Lymphatic Vessels Maintain the Nasal
Polarity during Corneal Inﬂammation. As we have observed
a nasal dominance in lymphatic vessels distribution in nor-
mal conjunctiva, we next determined whether this pattern
was preserved during corneal inﬂammation. As shown in
Figure 4(a), this nasal dominant arrangement was still main-
tained 2 weeks after corneal suture placement. The results
from repetitive studies were summarized in Figure 4(b) (P<
0.05).
3.4. Conjunctival Lymphatic Vessels Demonstrate More
Branching Points in the Nasal Side during Corneal Inﬂamma-
tion. To further characterize the novel ﬁndings on increased
conjunctival lymphatic density during corneal inﬂamma-
tion, we also examined the number of lymphatic branching
points between normal and inﬂamed condition at both
nasal and temporal sides. Our results showed a signiﬁcant
increase of lymphatic branching points in the conjunctiva
of the sutured cornea compared to the normal condition.
Moreover, it was found that this increase was largely due
to an increase of branching points in the nasal than in the
temporal side (Figures 5(a) and 5(b), P<0.05).
4. Discussion
Inthisstudy,wepresentnovelﬁndingsthatareimportantfor
our understanding of lymphatic vessels in the ocular surface,
which include both the cornea and the conjunctiva. Our4 Journal of Ophthalmology
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Figure 3: Comparison of lymphatic distribution in the conjunctiva between normal and inﬂamed conditions. (a) Representative
immunoﬂuorescent micrographs illustrating more lymphatic vessels in the conjunctiva of suture-induced inﬂamed cornea. LYVE-1: red.
Original magniﬁcation: ×50. (b) Summary of repetitive experiments. ∗P<0.05.
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Figure 4: Comparison of conjunctival lymphatic distribution in the nasal versus temporal side of the sutured cornea. (a) Representative
immunoﬂuorescent micrographs demonstrating that lymphatic vessels were more prominent in the nasal side. LYVE-1: red; Original
Magniﬁcation: ×50. (b) Summary of repetitive experiments. ∗P<0.05.Journal of Ophthalmology 5
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Figure 5: Comparison of branching points in conjunctival lymphatic vessels. (a) Signiﬁcant diﬀerence was found between conjunctival
lymphatic vessels under the normal and inﬂamed conditions at the nasal side ∗P<0.05. (b) Signiﬁcant diﬀerence was found in conjunctival
lymphatic branching points in the nasal versus temporal side under the inﬂamed condition. ∗P<0.05.
data on the physiological and pathological organization of
lymphatic vasculatures in the conjunctiva have shown that
conjunctival lymphatic vessels maintain a nasal dominant
distribution pattern under both normal and inﬂamed condi-
tions. This study also deﬁnes the conjunctiva as a new site for
LG response after an inﬂammatory stimulation in the ocular
surface.
To our knowledge, this is the ﬁrst study on the dis-
parate distribution of lymphatic vessels in the conjunctiva.
Nonetheless our ﬁndings are consistent with several previous
reports on polarized distribution of ocular tissues. For
example, we recently reported a similar nasal dominant
distribution of lymphatic vessels in the cornea [17]. The
analogous nasal preference pattern has also been observed
in antigen-induced conjunctiva-associated lymphoid tissue
(CALT) [22, 23], and limbal epithelial crypts [24]. A
more recent work byMckenna et al. also highlighted the
nasal polarization of eye innervation during embryonic
development [25]. Interestingly, dendritic cells of the bulbar
conjunctival stroma are more frequently located in the
superonasal quadrant [26]. In the clinic, it has been long
observed that certain ocular diseases, such as pinguecula and
pterygium, predominantly aﬀect the nasal side of the ocular
surface. Though the exact mechanisms remain unknown,
new evidence have conﬁrmed the presence of lymphatic
vessels in human pterygium [27]. Our ﬁndings that the nasal
side is naturally more endowed with lymphatic vessels may
explain partly why this side is more prone to pathological
disorders. Additionally, studies suggest that conjunctival
defect in dry eye disease (DED) begins in the nasal area
and spreads to the temporal area with disease progression
[28, 29]. Most recently, corneal LG was found to be critically
involved in DED [30]. Taken together, our data may provide
a new piece of evidence indicating a correlation between
lymphatic responseofthenasalsideoftheocularsurfaceand
DED pathogenesis, which warrants further investigation and
is beyond the scope of this study.
In spite of numerous studies on corneal LG with several
animal models including suture placement, transplantation,
micropocket implantation, herpes simplex virus infection,
and chemical burn [10], conjunctival LG has not been
yet reported. Our novel ﬁnding on conjunctival LG in
response to corneal inﬂammation indicates that lymphatic
vessels in the conjunctiva may play a more active role in
ocular surface diseases than previously considered. Yet to be
examined, conjunctival LG may also occur in other corneal
disorders after an infectious, traumatic, or chemical insult.
It is therefore important to consider both tissues together
when evaluating disease conditions and designing anti-LG
treatment regimens.
Finally, a comprehensive description of conjunctival
lymphaticsmayhaveimplication beyond the scopeoftheeye
as well. Unlike the cornea but similar to many other tissues
in the body, the conjunctiva has lymphatic supply under
normal condition. Results from conjunctival research should
therefore be readily applied to the other tissues. Due to its
accessible location in the ocular surface, we foresee that fur-
ther in-depth investigation on conjunctival lymphatics will
reveal novel mechanisms and therapies for broad lymphatic
diseases occurring both inside and outside the eye.
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